AINDEX
Markets

Carlsmed, Inc. (CARL)

CARLNASDAQ-GSMedical/Dental Instruments

$14.71

-1.34 (-8.35%) today

Closed, Nov 10, 4:00 PM ET

-8.35% 1D
Market cap
$401.62m
P/E
–
EPS, last 4 quarters
$-1.43
Dividend yield
–
Day range
–
52-week range
$8.50 to $17.23
Average volume
83.9k
Previous close
$16.05

Analysts

3 covering

Buy3 buy, 0 hold, 0 sell

Targets a year out average $24.00, +63.2% from here

$24.00now $14.71$24.00

Earnings

next estimate $-0.4100

Next report

Sep 2025

+11.1%

Dec 2025

+25.6%

Mar 2026

+25.6%

Jun 2026

+2.5%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue$13.07m$15.16m$16.12m$18.94m
Gross profit$9.93m$11.61m$12.43m$14.54m
Operating income-$9.04m-$9.32m-$9.28m-$11.04m
Net income-$8.53m-$8.61m-$8.70m-$10.51m

Last four quarters: revenue $63.30m, margin -57.4%, free cash flow -$34.58m

News

8 latest

The company

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.